|
Volumn 346, Issue 12, 2002, Pages 891-895
|
Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major
a,b b b b b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIFUNGAL AGENT;
FLUCONAZOLE;
PLACEBO;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
HUMAN;
LEISHMANIA MAJOR;
LEISHMANIASIS;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SKIN LEISHMANIASIS;
TREATMENT OUTCOME;
ADULT;
ANIMALS;
ANTIFUNGAL AGENTS;
DOUBLE-BLIND METHOD;
ENDEMIC DISEASES;
FEMALE;
FLUCONAZOLE;
FOLLOW-UP STUDIES;
HUMANS;
LEISHMANIA MAJOR;
LEISHMANIASIS, CUTANEOUS;
MALE;
MULTIVARIATE ANALYSIS;
PROPORTIONAL HAZARDS MODELS;
SAUDI ARABIA;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0037149717
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMoa011882 Document Type: Article |
Times cited : (292)
|
References (32)
|